Addiction

Nearly three out of four people who ever struggle with drug or alcohol use survive and go on to recovery, national estimates show.

Many new first-year Penn Medicine students had never administered or carried Narcan nasal spray before attending the school’s third consecutive naloxone “boot camp.”

Experts say stigma about addiction and lack of training among physicians and other medical workers often limits use of these drugs.

A drug task force, a county detective, and body scanner at a county jail are some of the proposed uses that county officials across the state have sought clarity on.

Safehouse first entered settlement negotiations with the U.S. Department of Justice in early 2022.

Deaths from overdoses of Xylazine-laced fentanyl have surged. The White House drug czar says he's marshalling efforts on testing, tracking, treatment, and stopping the spread.

The CDC concluded that by 2021, the "rate of drug overdose deaths involving xylazine was 35 times higher than the 2018 rate."

New Jersey lawmakers are going after fentanyl manufacturers and distributors to solve the state’s opioid crisis.

Xylazine is being mixed into fentanyl across the U.S., but who's doing it and why is a mystery. The government still doesn't identify and track new drug threats.

Over the course of the next 18 years, Delco will receive $63 million in settlement payments. Now comes the tough part. What should Delco spend the money on?

Philly takes first steps in distributing national opioid settlement funds with $1.9 million in grants for community and grassroots organizations.

The user wanted fentanyl, and paid with his life. Advocates and law enforcement agents agree the case illustrates the escalating dangers of fake pills.

Julius BaDour lost his job, quit his relationship, and left his hometown to live a life on the road. He learned some lessons about quitting along the way.

The nonprofit is teaming up with three hospital systems to provide people a direct path from the emergency room to supportive housing.

Under the plan, members of the wealthy Sackler family would give up ownership of Stamford, Connecticut-based Purdue, with its profits being used to fight the opioid crisis.